VCU Division of Hematology, Oncology & Palliative Care at Massey Cancer Center

What VCU Division of Hematology, Oncology & Palliative Care at Massey Cancer Center does

The VCU Division of Hematology, Oncology and Palliative Care operates within the Department of Internal Medicine at Virginia Commonwealth University School of Medicine and is integrally affiliated with the NCI-designated Massey Cancer Center. The division delivers clinical care, conducts research, and trains physicians, functioning as part of VCU Medical Center's broader role as a tertiary and quaternary referral center for the Mid-Atlantic region (spanning from the Washington D.C. metro area south into North Carolina and west into West Virginia). VCU Medical Center operates 743 inpatient beds and handles 843,700 ambulatory visits annually, of which 225,390 are Internal Medicine visits. The division specifically treats hematologic malignancies, solid tumors, and blood disorders, and provides palliative care for seriously ill patients, drawing on Massey Cancer Center's research infrastructure.

The division's research portfolio spans clinical, basic, and translational research, supported by $35.9 million in combined funding from the NIH, industry partners, the Department of Defense, and philanthropy. Educational programs include residency and fellowship training, with the broader Department of Internal Medicine hosting 120 residents and 115 fellows in subspecialty training drawn from 27 U.S. states. The division operates within an academic medical center holding multiple specialized accreditations, including NCI designation through Massey, Level 1 trauma center status, and the only Gold Center of Excellence in Cardio-Oncology in Virginia. Department Chair Dr. Patricia J. Sime has authored over 190 peer-reviewed manuscripts and holds patents for discoveries in inflammatory and fibrotic lung disease.

As a public state entity of the Commonwealth of Virginia and a division of Virginia Commonwealth University (founded 1838 as the medical department of Hampden-Sydney College, formally established as the Medical College of Virginia in 1854), the division operates under a state-university governance structure rather than a commercial ownership model. Revenue derives from clinical care billing (insurance, Medicare, Medicaid), research grants, state appropriations, and philanthropy. Patient care is delivered through direct physician encounters at VCU Medical Center and affiliated outpatient sites across Central Virginia, including the Adult Outpatient Pavilion, Stony Point, Mayland, and Reynold's Crossing campuses, with additional sites in Williamsburg, Tappahannock, and South Hill. The go-to-market model is referral-driven for tertiary and quaternary cases, supplemented by community outreach and the McGuire Veterans Affairs Medical Center teaching partnership.

Name

VCU Division of Hematology, Oncology & Palliative Care at Massey Cancer Center

Legal name

Virginia Commonwealth University School of Medicine

Website

https://intmed.vcu.edu

Company type

Private

Founded year

1838

Operating status

Operating

Headcount range

11–50 employees

Short description

The VCU Division of Hematology, Oncology and Palliative Care is an academic medical division within VCU's Department of Internal Medicine and NCI-designated Massey Cancer Center, delivering tertiary clinical care, research, and physician training across Virginia and the Mid-Atlantic region.

Ownership category

akta.pro rank

Product category

Academic Cancer Care Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Offices of Physicians (62111), General Medical and Surgical Hospitals (622110)

SIC

Services-Hospitals (8060), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM), Academic Medical Centers & Teaching Hospitals (University-Affiliated) (EDAHAGAA), Specialty Palliative Care (e.g., oncology, CHF/COPD, dementia) (HLADAHAJ)

Keywords

• Hematology oncology care
• Cancer treatment services
• Palliative care services
• Academic medical research
• Medical education training

Headquarters

HQ city

Richmond

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Clinical Care Revenue: Revenue generated through patient care services including inpatient admissions, outpatient consultations, and procedures at VCU Medical Center and affiliated clinical sites. The hospital has 743 in-patient beds and 843,700 ambulatory visits (225,390 Internal Medicine).
2. Research Funding: Grant-funded research supported by $35.9M from NIH, Industry, Department of Defense, and Philanthropy. Department is integrally affiliated with NCI-designated Massey Cancer Center and Pauley Heart Center.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

The division delivers subspecialty clinical care in hematology, oncology, and palliative care to patients in central Virginia and the broader Mid-Atlantic region, supported by VCU Medical Center's 743 inpatient beds. It conducts NIH-, DoD-, industry-, and philanthropy-funded translational and clinical research, including cancer trials through the NCI-designated Massey Cancer Center. It also provides graduate medical education through internal medicine residency and subspecialty fellowship programs, training 120 residents and 115 fellows currently in the broader Department of Internal Medicine.

Product overview

No specific product or service information available for this division in the provided sources.

Differentiator

Problem solved

Functional benefit

Brands

• Massey Cancer Center: NCI-designated cancer center affiliated with the Division of Hematology, Oncology & Palliative Care

Products and services

• Hematology, Oncology & Palliative Care Clinical Services Subspecialty clinical care for hematologic malignancies, solid tumors, blood disorders, and palliative/supportive care delivered through VCU Medical Center inpatient and outpatient sites to patients in Virginia and the Mid-Atlantic region.
• Clinical Trials and Translational Research (Massey Cancer Center) NIH-, DoD-, industry-, and philanthropy-funded clinical, translational, and basic science research conducted through the NCI-designated Massey Cancer Center, including investigator-initiated and sponsored oncology trials for patients with cancer and blood disorders.
• Internal Medicine Residency Program Graduate medical education program training 120 residents across the Department of Internal Medicine, including clinical rotations at VCU Medical Center and the McGuire Veterans Affairs Medical Center.
• Subspecialty Fellowship Programs Fellowship training across internal medicine subspecialties including hematology/oncology and palliative care, currently supporting 115 fellows in subspecialty training within the Department of Internal Medicine.
• Global Health Research and Training Programs (Rwanda, Uganda)

Quantifiable outcome

• VCU Medical Center ranked #1 in metro-Richmond area by U.S. News & World Report (2019)
• +5 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

17 partnerships are on record, tiered core and major.

• Massey Cancer Center (NCI-designated)coreStrategic or Co-development PartnerThe Division of Hematology, Oncology and Palliative Care is integrally affiliated with the NCI-designated Massey Cancer Center. The Department of Internal Medicine collaborates with Massey on innovative research and clinical care across cancer treatment, clinical trials, and translational research.
• VCU Health Pauley Heart CentercoreStrategic or Co-development PartnerThe Department of Internal Medicine is integrally affiliated with the Pauley Heart Center, which incorporates innovative research and clinical care. Pauley Heart Center has achieved #1 ranking in Virginia for cardiology and heart surgery (U.S. News & World Report 2025-26).
• McGuire Veterans Affairs Medical CentercoreStrategic or Co-development PartnerVCU Medical Center and the McGuire Veterans Administration Medical Center are the teaching institutions for residency and fellowship training programs. Division of Nephrology has a nephrology and transplant program at the McGuire VAMC.
• Stravitz-Sanyal Institute for Liver Disease and Metabolic HealthcoreStrategic or Co-development PartnerThe Stravitz-Sanyal Institute for Liver Disease and Metabolic Health at VCU is a major institute collaborating with the Department of Internal Medicine on liver disease research and clinical care. The institute is directed by Dr. Arun Sanyal.
• University of Rwanda College of Medicine and Health SciencescoreStrategic or Co-development PartnerVCU's Division of Pulmonary Disease and Critical Care Medicine collaborates with the University of Rwanda College of Medicine and Health Sciences on sepsis research, critical care education (FCCS courses), and clinical exposure programs for Rwandan physician trainees. This includes a randomized controlled trial of high-dose intravenous vitamin C for sepsis treatment.
• Makerere University Lung Institute (Uganda)coreStrategic or Co-development PartnerVCU's Division of Pulmonary Disease and Critical Care Medicine partnered with Makerere University Lung Institute in Uganda to establish the Uganda Bronchoscopy and Pleural Program (UBP) in 2019, providing equipment and training clinicians to create the first public bronchoscopy program in Uganda.
• Harvard Medical School (Dr. Beth Riviello)coreStrategic or Co-development PartnerVCU collaborates with Dr. Beth Riviello at Harvard Medical School on sepsis research and critical care capacity building in Rwanda, including the randomized controlled trial of high-dose intravenous vitamin C as an adjunctive treatment for sepsis.
• University of VirginiacoreStrategic or Co-development PartnerVCU collaborated with the University of Virginia on the Clinical Exposure Program for Rwandan physician trainees, supporting two Rwandan physician trainees every year for one-month rotations in various Intensive Care Units at VCU.
• American Thoracic SocietymajorStrategic or Co-development PartnerDr. Patricia J. Sime has served in high-level leadership roles for the American Thoracic Society and routinely serves as an advisor and reviewer for the NIH and prominent journal editorial boards.
• Society of Critical Care Medicine (SCCM)coreStrategic or Co-development PartnerVCU-PCCM Global Health Program conducts yearly Fundamental Critical Care Support (FCCS) courses in Rwanda with support from SCCM, with the goal of developing local instructors and tailoring the course to the local environment.
• University of MinnesotacoreStrategic or Co-development PartnerVCU collaborates with Dr. Jennifer Rickard at the University of Minnesota (and University of Rwanda) on the randomized controlled trial of high-dose intravenous vitamin C for sepsis in Rwanda.
• University of Miami (Dr. Trishul Siddharthan)coreStrategic or Co-development PartnerVCU collaborates with Dr. Trishul Siddharthan at the University of Miami Division of Pulmonary and Critical Care Medicine on projects investigating interstitial lung disease and chronic respiratory disease in Uganda.
• American Society of Transplantation (AST)coreStrategic or Co-development PartnerDr. Gaurav Gupta serves on the National AST Kidney/Pancreas Executive Committee Co-Chair and AST Transplant Nephrology Fellowship Board of Managers. Dr. Gupta chairs the AST Kidney/Pancreas Committee's Education workgroup.
• United Network of Organ Sharing (UNOS)majorStrategic or Co-development PartnerDr. Gaurav Gupta has served on various national committees for UNOS, which manages the nation's organ transplant system.
• Pulmonary Hypertension AssociationcoreStrategic or Co-development PartnerVCU's Pulmonary Hypertension Center is accredited by the Pulmonary Hypertension Association as a Comprehensive Care Center. Dr. Daniel Grinnan served as Chair of the PHA Registry Steering Committee (2019-2022) and PHA Accreditation Committee (2022-2024), and currently chairs the PHA Oversight Committee.
• Lupus Foundation of AmericamajorStrategic or Co-development PartnerDr. Beth Rubinstein serves on the Medical Advisory Council for the Lupus Foundation of America.
• Virginia Society of RheumatologymajorStrategic or Co-development PartnerDr. Beth Rubinstein is an executive board member of the Virginia Society of Rheumatology and contributes to the annual national ACR CME/MOC examination through the ACR CARE Committee.

Scale indicators15 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• MD Anderson Cancer Center: The leading U.S. NCI-designated comprehensive cancer center. Functions as a broad incumbent in academic oncology — does not directly compete regionally with VCU Massey but sets the standard for NCI-designated programs and competes for national clinical trial allocations and faculty.

Direct peers

• UNC Lineberger Comprehensive Cancer Center: NCI-designated comprehensive cancer center at UNC-Chapel Hill. Comparable in scope (academic, NCI-designated, regional referral) and competes in the same North Carolina catchment. Strong training pipeline and translational research portfolio mirror VCU Massey.
• Johns Hopkins Sidney Kimmel Cancer Center: NCI-designated comprehensive cancer center at Johns Hopkins, the dominant Mid-Atlantic academic cancer program. Highly comparable in mission, training, and research, but operates at significantly larger scale and brand prestige; competes directly for complex oncology referrals and NIH funding.
• Vanderbilt-Ingram Cancer Center: NCI-designated comprehensive cancer center at Vanderbilt University Medical Center. Comparable as an academic NCI-designated center with strong translational research portfolio, training programs, and clinical trials infrastructure; competes for industry-sponsored trials and federal funding.
• Duke Cancer Institute: NCI-designated comprehensive cancer center at Duke University serving the Carolinas/Mid-Atlantic region. Comparable in academic structure, NCI designation, training programs, and clinical trials portfolio; competes with VCU for the same tertiary referral base in North Carolina.
• Georgetown Lombardi Comprehensive Cancer Center: NCI-designated cancer center at Georgetown University Medical Center in Washington D.C., the only NCI-designated center in the District. Directly comparable as a Mid-Atlantic academic cancer program and competes with VCU for D.C. metro patient referrals and research collaborations.
• Emory Winship Cancer Institute: NCI-designated comprehensive cancer center at Emory University in Atlanta. Comparable as an academic NCI-designated Southeast regional referral center with training and clinical research programs comparable to VCU Massey.
• University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center: NCI-designated comprehensive cancer center at the University of Maryland Medical Center. Directly comparable as a Mid-Atlantic NCI-designated academic cancer program with similar training and research portfolio, competing with VCU for the same regional catchment.
• University of Virginia Cancer Center: Virginia-based NCI-designated academic cancer center within UVA Health, the closest in-state peer. Directly comparable as a Mid-Atlantic NCI-designated comprehensive cancer center with similar training and research portfolio, competing with VCU Massey for the same regional patient catchment.
• University of Pittsburgh Hillman Cancer Center: NCI-designated comprehensive cancer center at UPMC Hillman, the dominant Mid-Atlantic academic cancer center in Pennsylvania. Comparable in academic structure, NCI designation, training scale, and translational research, with similar regional referral model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/VCU
• YouTubeyoutube.com/vcu
• Facebookfacebook.com/VCU
• LinkedInlinkedin.com/company/virginia-commonwealth-university-division-of-hematology-oncology-and-palliative-care
• Instagraminstagram.com/vcu

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about VCU Division of Hematology, Oncology & Palliative Care at Massey Cancer Center